Acceptance of tamoxifen chemoprevention by physicians and women at risk.
McKay
Andrew
A
Latosinsky
Steve
S
Martin
Wanda
W
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000517:prevention & control*; D018890:Chemoprevention; D003657:Decision Making; D005260:Female; D006801:Humans; D010342:Patient Acceptance of Health Care; D010817:Physician-Patient Relations; D011446:Prospective Studies; D018570:Risk Assessment; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen